The table below shows BIO-TECHNE Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$1.22B
$1.16B
$1.14B
-
-
-
Cost of revenue
$429.36M
$389.33M
$366.89M
$349.10M
$298.18M
$255.50M
Gross profit
$790.27M
$769.73M
$769.82M
$756.50M
$632.85M
$483.19M
R&D
-
-
-
-
-
-
SG&A
TECH annual revenue (10-K history)
BIO-TECHNE Corp reported annual revenue of $1.22B for fiscal year 2025. That is up 5.2% from $1.16B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $499.02M (FY 2016) to $1.22B. Figures come from the company's audited annual reports as filed with the SEC.
